Skip Navigation

Neuro-Oncology 2003 5(3):168-178; doi:10.1215/S1152851702000443
© 2003 by Society
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Perry, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Perry, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 by the Society forNeuro-Oncology

Pathology of low-grade gliomas: An update of emerging concepts

Arie Perry1

Division of Neuropathology, Washington University School of Medicine,St. Louis, MO 63110, USA

1 Address correspondence to Arie Perry, Division of Neuropathology, Box 8118,Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO63110-1093, USA(aperry{at}pathology.wustl.edu)


   Abstract

Although the term low-grade glioma (LGG) is useful for itsconnotation of a slow-growing, better prognosis CNS primary neoplasm typicallyoccurring in a young patient, it also serves as a potential diagnosticwastebasket, occasionally leading to conceptual errors, therapeuticuncertainty, or misinterpretation of clinical data. For example, the LGGdesignation is occasionally invoked as a justification for lumping togetherbiologically unrelated entities such as pilocytic astrocytoma and diffuseastrocytoma. Whereas the former represents a benign and potentially surgicallycurable neoplasm that virtually never undergoes malignant transformation, thelatter is a surgically incurable low-grade malignancy, prone to furthermalignant progression and eventual fatality. Therefore, although rare caseslacking a clear distinction may be encountered, the term LGG should beabandoned for a more specific diagnosis whenever possible. The primary goalsof this paper are to review practical surgical pathology issues related to thediagnosis of diffuse LGGs and to update the reader on emergingclinicopathologic and molecular genetic concepts. Also discussed are currentcontroversies of classification/grading and the role of ancillary testing viaimmunohistochemical and genetic techniques.

Received November 5, 2002; Accepted December 13, 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Neuro OncologyHome page
R. S. Arora, R. D. Alston, T. O.B. Eden, E. J. Estlin, A. Moran, and J. M. Birch
Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England
Neuro Oncology, August 1, 2009; 11(4): 403 - 413.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
L. Massimi, D. Battaglia, G. Paternoster, D. Martinelli, C. Sturiale, and C. Di Rocco
Segmental Spinal Myoclonus and Metastatic Cervical Ganglioglioma: An Unusual Association
J Child Neurol, March 1, 2009; 24(3): 365 - 369.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. Bartha, J.F. Megyesi, and C.J. Watling
Low-Grade Glioma: Correlation of Short Echo Time 1H-MR Spectroscopy with 23Na MR Imaging
AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 464 - 470.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Z. Rumboldt, D.L.A. Camacho, D. Lake, C.T. Welsh, and M. Castillo
Apparent Diffusion Coefficients for Differentiation of Cerebellar Tumors in Children
AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1362 - 1369.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.